Rhea-AI Summary
TRexBio (TRXB) priced its initial public offering of common stock at $14.00 per share, with all shares offered by the company. The offering comprises 8,333,334 shares and is expected to generate approximately $116.7 million in gross proceeds before underwriting discounts, commissions and other offering expenses.
Trading is expected to begin on the Nasdaq Global Select Market on October 9, 2026. Closing is expected on October 13, 2026, subject to customary closing conditions. Underwriters have a 30-day option to purchase up to an additional 1,250,000 shares at the IPO price, less underwriting discounts and commissions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags